NanoViricides Other Current Liabilities

NanoViricides (NNVC) currently reports a other current liabilities of $930B as of March 2026. That compares with $490K in the prior-year period — up 188644368.1% year over year. Use the charts on this page to explore NanoViricides's other current liabilities history and peer comparisons.

NanoViricides's other current liabilities increased from $490K to $930B — a 188644368.1% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

NanoViricides reported $930B in other current liabilities as of March 2026. That compares with $490K in the prior-year period — up 188644368.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $930B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for NanoViricides, and consider following NNVC for alerts when major investors trade the stock.

NanoViricides is classified in the Healthcare sector. On other current liabilities, it currently shows $930B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing NNVC with unrelated industries.